https://www.modernatx.com | United States | 2010 | $1960.83M
Moderna is a biotechnology company based in the United States focused on developing messenger RNA (mRNA) therapeutics and vaccines. Founded in 2010, the company has raised over $2 billion in venture capital funding and went public in 2018 through a record-breaking IPO. Moderna has assembled a team of experienced founders and leaders, including CEO Stéphane Bancel, and has formed partnerships with various pharmaceutical and biotech companies to advance its mRNA-based drug discovery and development efforts across multiple therapeutic areas.
